Smart Asthma Monitoring Device Market Share

  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Smart Asthma Monitoring Device Market Share

North American Market Forecast

North America industry is likely to hold largest revenue share of 38% by 2037. The regional market growth can be attributed to the high incidence of asthma in developed nations. According to the Asthma and Allergy Foundation of America (AAFA), over 25 million Americans deal with asthma, including 5.1 million children below the age of 18. 

Healthcare experts believe that asthma is directly related to urbanization, as the urban lifestyle includes more exposure to air pollution, which is among the major causes of high cases of asthma in the U.S.

APAC Market Statistics

In the Asia Pacific region, the smart asthma monitoring device market is expected to grow significantly throughout the projected period. The regional market growth can be estimated on the back of the high geriatric population, along with the rising cases of asthma, as older people are more vulnerable to respiratory diseases, especially in India and China. In China, more than 4.2% population gets affected by asthma which is 45.7 million Chinese adults in which most of whom are old people.

Moreover, the growing adoption of innovative medical equipment in the APAC region is estimated to boost market expansion.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.

The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.

The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample